Cytokines and oxidative signalling in skeletal muscle.

A growing body of literature indicates that cytokines regulate skeletal muscle function, including gene expression and adaptive responses. Tumour necrosis factor-alpha (TNF-alpha) is the cytokine most prominently linked to muscle pathophysiology and, therefore, has been studied most extensively in muscle-based systems. TNF-alpha is associated with muscle catabolism and loss of muscle function in human diseases that range from cancer to heart failure, from arthritis to AIDS. Recent advances have established that TNF-alpha causes muscle weakness via at least two mechanisms, accelerated protein loss and contractile dysfunction. Protein loss is a chronic response that occurs over days to weeks. Changes in gene expression required for TNF-alpha induced catabolism are regulated by the transcription factor nuclear factor-kappaB which is essential for the net loss of muscle protein caused by chronic TNF-alpha exposure. Contractile dysfunction is an acute response to TNF-alpha stimulation, developing over hours and resulting in decreased force production. Both actions of TNF-alpha involve a rapid rise in endogenous oxidants as an essential step in post-receptor signal transduction. These oxidants appear to include reactive oxygen species derived from mitochondrial electron transport. Such information provides insight into the cellular and molecular mechanisms of TNF-alpha action in skeletal muscle and establishes a scientific basis for continued research into cytokine signalling.

[1]  R. Henry,et al.  The expression of TNF alpha by human muscle. Relationship to insulin resistance. , 1996, The Journal of clinical investigation.

[2]  R. Bravo,et al.  Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. , 1997, Genes & development.

[3]  P. Wilcox,et al.  High-dose tumor necrosis factor alpha produces an impairment of hamster diaphragm contractility. Attenuation with a prostaglandin inhibitor. , 1996, American journal of respiratory and critical care medicine.

[4]  A. Goldberg,et al.  Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. , 1997, The Journal of clinical investigation.

[5]  F. Clubb,et al.  Cardiac-Specific Overexpression of Tumor Necrosis Factor-&agr; Causes Oxidative Stress and Contractile Dysfunction in Mouse Diaphragm , 2000, Circulation.

[6]  F. Authier,et al.  Interleukin (IL)-1 beta and IL-1 beta mRNA expression in normal and diseased skeletal muscle assessed by immunocytochemistry, immunoblotting and reverse transcriptase-nested polymerase chain reaction. , 1997, Journal of neuropathology and experimental neurology.

[7]  P. Wilcox,et al.  Monocyte inflammatory mediators impair in vitro hamster diaphragm contractility. , 1992, The American review of respiratory disease.

[8]  A. Oliff,et al.  Tumors secreting human TNF/cachectin induce cachexia in mice , 1987, Cell.

[9]  B. Klebl,et al.  Protein oxidation, tyrosine nitration, and inactivation of sarcoplasmic reticulum Ca2+‐ATPase in low‐frequency stimulated rabbit muscle , 1998, FEBS letters.

[10]  L. Tessitore,et al.  Humoral mediation for cachexia in tumour-bearing rats. , 1993, British Journal of Cancer.

[11]  K. Tracey,et al.  Tumor necrosis factor, other cytokines and disease. , 1993, Annual review of cell biology.

[12]  R. Budgett,et al.  Fatigue and underperformance in athletes: the overtraining syndrome. , 1998, British journal of sports medicine.

[13]  Peter Schjerling,et al.  Pro‐ and anti‐inflammatory cytokine balance in strenuous exercise in humans , 1999, The Journal of physiology.

[14]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[15]  C. Sen,et al.  Glutathione Regulation of Tumor Necrosis Factor-α-Induced NF-κB Activation in Skeletal Muscle-Derived L6 Cells☆ , 1997 .

[16]  B Chance,et al.  Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.

[17]  R. Zittoun,et al.  Fatigue in cancer patients. , 1999, Current opinion in oncology.

[18]  P. Diaz,et al.  Tumor necrosis factor and endotoxin do not directly affect in vitro diaphragm function. , 1993, The American review of respiratory disease.

[19]  J. Fischer,et al.  The expression of genes in the ubiquitin-proteasome proteolytic pathway is increased in skeletal muscle from patients with cancer. , 1999, Surgery.

[20]  B. Beutler,et al.  Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells , 1985, The Journal of experimental medicine.

[21]  Jack F. Fowler,et al.  Brief summary of radiobiological principles in fractionated radiotherapy , 1992 .

[22]  M. Daucher,et al.  Activation of the serum response factor by p65/NF‐kappaB. , 1996, The EMBO journal.

[23]  N. Agell,et al.  Ubiquitin and proteasome gene expression is increased in skeletal muscle of slim AIDS patients. , 1998, International journal of molecular medicine.

[24]  M. Hess,et al.  Inhibition by free radical scavengers and by cyclooxygenase inhibitors of the effect of acidosis on calcium transport by masseter muscle sarcoplasmic reticulum. , 1985, Biochemical pharmacology.

[25]  S. Chakraborti,et al.  Oxidant, mitochondria and calcium: an overview. , 1999, Cellular signalling.

[26]  C. Sen,et al.  Antioxidant and redox regulation of gene transcription , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  L. Moldawer,et al.  Tumor necrosis factor and cachexia: a current perspective. , 1994, Surgical oncology.

[28]  S. Hamilton,et al.  RyR1 modulation by oxidation and calmodulin. , 2000, Antioxidants & redox signaling.

[29]  R. Schwartz,et al.  Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-κB activation in response to tumor necrosis factor α , 1998 .

[30]  R. Hohlfeld,et al.  Constitutive and cytokine-induced production of interleukin-6 by human myoblasts. , 1994, Immunology letters.

[31]  H. R. Chang,et al.  The role of cytokines in the catabolic consequences of infection and injury. , 1998, JPEN. Journal of parenteral and enteral nutrition.

[32]  J. Devynck,et al.  Superoxide release from interleukin-1B-stimulated human vascular cells: in situ electrochemical measurement. , 1999, Free radical biology & medicine.

[33]  M. Reid,et al.  Exogenous reactive oxygen and nitric oxide alter intracellular oxidant status of skeletal muscle fibres. , 1999, Acta physiologica Scandinavica.

[34]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[35]  J. Oyama,et al.  Role of superoxide anion in the pathogenesis of cytokine-induced myocardial dysfunction in dogs in vivo. , 1999, Cardiovascular research.

[36]  N. Agell,et al.  Tumour necrosis factor‐α increases the ubiquitinization of rat skeletal muscle proteins , 1993 .

[37]  D. Allen,et al.  Effect of hydrogen peroxide and dithiothreitol on contractile function of single skeletal muscle fibres from the mouse , 1998, The Journal of physiology.

[38]  W. Declercq,et al.  Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies 1 This paper was presented at the 50th Annual Meeting of the American Academy of Neurology, Minneapolis, MN, USA, April 1998. 1 , 1999, Neuromuscular Disorders.

[39]  L. Ji,et al.  Aging and acute exercise enhance free radical generation in rat skeletal muscle. , 1999, Journal of applied physiology.

[40]  K. Tracey,et al.  Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation , 1988, The Journal of experimental medicine.

[41]  Chris Albanese,et al.  NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1 , 1999, Molecular and Cellular Biology.

[42]  N. Agell,et al.  Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knockout mice , 1998, Molecular and Cellular Endocrinology.

[43]  A. Goldberg,et al.  Activation of protein breakdown and prostaglandin E2 production in rat skeletal muscle in fever is signaled by a macrophage product distinct from interleukin 1 or other known monokines. , 1988, The Journal of clinical investigation.

[44]  M. Choudhry,et al.  Sepsis-induced myofibrillar protein catabolism in rat skeletal muscle. , 1994, Life sciences.

[45]  J. Hancock Superoxide, hydrogen peroxide and nitric oxide as signalling molecules: their production and role in disease. , 1997, British journal of biomedical science.

[46]  L. Tartaglia,et al.  Two TNF receptors. , 1992, Immunology today.

[47]  J. Faulkner,et al.  Free radical activity following contraction-induced injury to the extensor digitorum longus muscles of rats. , 1999, Free radical biology & medicine.

[48]  M. Lamy,et al.  Endotoxaemia, production of tumour necrosis factor α and polymorphonuclear neutrophil activation following strenuous exercise in humans , 1998, European Journal of Applied Physiology and Occupational Physiology.

[49]  M. Buck,et al.  Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. , 1996, The EMBO journal.

[50]  Michael Karin,et al.  Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.

[51]  M. Tisdale Wasting in cancer. , 1999, The Journal of nutrition.

[52]  Javier Naval,et al.  Implication of Mitochondrial Hydrogen Peroxide Generation in Ceramide-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[53]  G. Friman,et al.  Acute infection: metabolic responses, effects on performance, interaction with exercise, and myocarditis. , 1998, International journal of sports medicine.

[54]  K. Walley,et al.  Tumor necrosis factor alpha decreases in vivo diaphragm contractility in dogs. , 1994, American journal of respiratory and critical care medicine.

[55]  N. Agell,et al.  TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. , 1997, Biochemical and biophysical research communications.

[56]  J. Robbins,et al.  Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. , 1991, The Journal of biological chemistry.

[57]  A. Dimarco,et al.  Formation of reactive oxygen species by the contracting diaphragm is PLA(2) dependent. , 1999, Journal of applied physiology.

[58]  N. Agell,et al.  Ubiquitin Gene Expression in Skeletal Muscle Is Increased by Tumor Necrosis Factor-α , 1994 .

[59]  N. Agell,et al.  Protein turnover in skeletal muscle of tumour-bearing transgenic mice overexpressing the soluble TNF receptor-1. , 1998, Cancer letters.

[60]  A. Goldberg,et al.  Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. , 1996, The New England journal of medicine.

[61]  N. Agell,et al.  Ubiquitin gene expression in skeletal muscle is increased during sepsis: involvement of TNF-alpha but not IL-1. , 1995, Biochemical and biophysical research communications.

[62]  T. Takishima,et al.  TNF-alpha mRNA expression in diaphragm muscle after endotoxin administration. , 1995, American journal of respiratory and critical care medicine.

[63]  J. Stamler,et al.  Nitric oxide modulates excitation-contraction coupling in the diaphragm. , 1998, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[64]  A. Dimarco,et al.  Modulation of release of reactive oxygen species by the contracting diaphragm. , 2000, American journal of respiratory and critical care medicine.

[65]  J. Sweatt,et al.  Mitochondria Mediate Tumor Necrosis Factor-α/NF-κB Signaling in Skeletal Muscle Myotubes , 1999 .

[66]  F. López‐Soriano,et al.  Catabolic proinflammatory cytokines. , 1998, Current opinion in clinical nutrition and metabolic care.

[67]  K. H. Lee,et al.  NF-kappaB-dependent expression of nitric oxide synthase is required for membrane fusion of chick embryonic myoblasts. , 1997, The Biochemical journal.

[68]  M. Karin,et al.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.

[69]  C. Tolias,et al.  Astrocytes rather than neurones mediate interleukin-1β dependent nitric oxide and superoxide radical release in primary hypothalamic rat cell cultures , 1999, Neuroscience Letters.

[70]  M. Tsukamoto,et al.  Superoxide production from paraquat evoked by exogenous NADPH in pulmonary endothelial cells. , 1999, Free radical biology & medicine.

[71]  J. Gamble,et al.  The effects of recombinant tumour necrosis factor (cachectin) on metabolism in isolated rat adipocyte, hepatocyte and muscle preparations. , 1987, The Biochemical journal.

[72]  J. Tayek Effects of tumor necrosis factor alpha on skeletal muscle amino acid metabolism studied in-vivo. , 1996, Journal of the American College of Nutrition.

[73]  M. Palacín,et al.  Insulin-like Growth Factor-II, Phosphatidylinositol 3-Kinase, Nuclear Factor-κB and Inducible Nitric-oxide Synthase Define a Common Myogenic Signaling Pathway* , 1999, The Journal of Biological Chemistry.

[74]  Moldawer Ll,et al.  Human immunodeficiency virus-associated wasting and mechanisms of cachexia associated with inflammation. , 1998, Seminars in oncology.

[75]  M. Hochstrasser Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. , 1995, Current opinion in cell biology.

[76]  S. Anker,et al.  Insights into the pathogenesis of chronic heart failure: immune activation and cachexia. , 1999, Current opinion in cardiology.

[77]  M. Farber,et al.  Tissue wasting in patients with chronic obstructive pulmonary disease. , 2000, Neurologic clinics.

[78]  C. Lang,et al.  Mechanism of IL-1 induced inhibition of protein synthesis in skeletal muscle. , 1999, Shock.

[79]  B. Beutler,et al.  Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.